©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 112924
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.112924
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.112924
Table 1 Clinicopathological characteristics of 445 patients, n (%)
| Clinicopathologic characteristics (n = 445) | Result |
| Age, years, median (range) | 61.83 (38-87) |
| Sex | |
| Female | 250 (56.18) |
| Male | 195 (43.82) |
| Site | |
| Colon | 305 (68.54) |
| Rectum | 140 (31.46) |
| CEA | |
| < 5 ng/mL | 255 (57.30) |
| ≥ 5 ng/mL | 190 (42.70) |
| Histologic differentiation | |
| Differentiated | 390 (87.64) |
| Others | 55 (12.36) |
| TNM stage | |
| II | 180 (40.45) |
| III | 265 (59.55) |
- Citation: Kong FF, Geng X, Liu RM, Zhang WT, Quan B, Zhong Y, Zhu YL. Post-chemotherapy C-reactive protein/albumin ratio predicts prognosis in stage II-III colorectal cancer. World J Gastrointest Surg 2026; 18(2): 112924
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/112924.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.112924